A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
RITuximab AntiphosPholipid Syndrome (RITAPS) Study is designed to evaluate whether a
medication called rituximab would reduce the signs and symptoms of antiphospholipid antibody
(aPL) -related certain clinical problems.